Webinars
Upcoming Webinars
FierceMarkets Webinars are interactive web events focusing on important issues and opportunities. Event are led by experts from our editorial staff and often feature presentations from knowledgeable industry insiders. Attendee participation and Q&A is an integral part of each presentation.
On Demand Webinars
It's not too late! Even if you miss the live webcast of a FierceMarkets Webinar, you can stream past webinars from the links on this page.
Finding Sources to Fund a Biotech Start-up
Last year, biotech companies snared a growing share of the billions of dollars in venture capital earmarked for emerging companies. Much of that venture cash has traditionally been channeled toward
Making the Business Case for Green Meetings
How to Make a Difference while Achieving Your Cost Reduction Goals With climate change and corporate social responsibility dominating the headlines, it’s good business practice to learn how to
Animal Based Therapeutics in Human Drug Development
New Zealand has an unrivalled position with an impeccable animal health status, food safety and traceability programs. It has some of the safest ingredients available for large scale drug development
Maryland: The Competitive Advantage in Biodefense and Infection Disease Research
Learn about the economic development incentives in Maryland, and how companies can benefit by locating in this hotspot. Hear the stories behind Maryland companies in the biodefense and public health
Economic Development Trends - Choosing Your Location
Mapping the future of economic development trends in biotech:
Which economic development groups are offering the sweetest rewards, and how do you compare? Start-ups are looking for every kind of
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

